Market Cap (In USD)
774.96 Thousand
Revenue (In USD)
-
Net Income (In USD)
16.02 Million
Avg. Volume
38.13 Million
- Currency
- USD
- Country
- Financial Services
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-7.0E-4
- PE
- -
- EPS
- -
- Beta Value
- -1.77
- ISIN
- US72703D1000
- CUSIP
- -
- CIK
- 1317880
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Roger Baylis-Duffield
- Employee Count
- -
- Website
- https://www.plandaibiotech.com
- Ipo Date
- 1995-02-02
- Details
- Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
More Stocks
-
KIRLOSINDKirloskar Industries Limited
KIRLOSIND
-
DOM
-
0456
-
ENAFF
-
PSCO
-
009270ShinWon Corporation
009270
-
VIDAVidaroo Corp
VIDA
-
THVB